Introduction Comorbidities significantly impact the clinical span of idiopathic pulmonary fibrosis (IPF). significant positive effect on success. A significant effect of comorbidities connected therapies on success was not found out. This included the usage of proton pump inhibitors at baseline, that was not connected with a success advantage (p = 0.718). We also founded a… Continue reading Introduction Comorbidities significantly impact the clinical span of idiopathic pulmonary fibrosis